Professor Jonathan Wall and his team at the UT Graduate School of Medicine have spent more than two decades investigating systemic amyloidosis. Their work played an integral role in helping launch the biopharmaceutical company Attralus with technology licensed from UTRF. Today, Attralus announced that it has secured $25 million in investment financing to work on (read more)
Multi Campus Office
UTRF’s Commercialization Analyst Program Goes Virtual, Offers Unique Commercialization Insight
For the past nine years, the University of Tennessee Research Foundation’s internship program has offered valuable career experience to UT law students, graduate students, and post-doctoral researchers interested in the commercialization process of innovations from the University of Tennessee. This year, the program has gone virtual due to the COVID-19 pandemic. Interns in UTRF’s Commercialization (read more)
UTRF Inventor Spotlight: Dr. Feng-Yuan Zhang
Making Electrolysis More Affordable and Efficient With zero carbon emissions, hydrogen is a promising alternative fuel and energy storage medium that may help power more vehicles, provide electricity, reduce carbon dioxide to high-value products, produce next-generation ammonia, and heat buildings in the movement toward a sustainable future. There’s just one catch: though hydrogen use doesn’t (read more)